Atuss Da
NDC Package 67523-101-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Atuss Da is this combination medication is used to relieve symptoms caused by the common cold, flu, allergies, "hay fever," and other breathing illnesses (such as sinusitis, bronchitis). Marketed by Aber Pharmaceuticals, Llc, this product is identified by NDC 67523-101 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
67523-101-15
Package Description
6 BOTTLE in 1 CARTON / 15 mL in 1 BOTTLE
Product Code
11-Digit Billing Format
67523010115

Clinical Specifications

Proprietary Name
Atuss Da
Dosage Form
-
Usage Information
This combination medication is used to relieve symptoms caused by the common cold, flu, allergies, "hay fever," and other breathing illnesses (such as sinusitis, bronchitis). These symptoms include cough, watery eyes, itchy eyes/nose/throat, runny nose, and sneezing. This product contains a cough suppressant (such as chlophedianol) that affects a certain part of the brain, reducing the urge to cough. This product also contains a decongestant (such as pseudoephedrine, phenylephrine), which helps relieve stuffy nose symptoms. It also contains an antihistamine (such as brompheniramine, triprolidine, among others), which helps relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing. This medication is not usually used for ongoing coughs from smoking, asthma, or other long-term breathing problems (such as emphysema), or for coughs with a lot of mucus, unless directed by your doctor. Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms

Regulatory & Marketing

Labeler Name
Aber Pharmaceuticals, Llc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
02-08-2016
End Marketing Date
01-31-2018
Listing Expiration
01-31-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (67523-101). Click a package code to view its specific billing and regulatory data.

118 mL in 1 BOTTLE
473 mL in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67523-101-15 identifies a specific commercial package of 6 bottle in 1 carton / 15 ml in 1 bottle of Atuss Da, labeled by Aber Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aber Pharmaceuticals, Llc on February 08, 2016. The current certification is valid through January 31, 2018.

What are the primary indications for this medication?

This combination medication is used to relieve symptoms caused by the common cold, flu, allergies, "hay fever," and other breathing illnesses (such as sinusitis, bronchitis). These symptoms include cough, watery eyes, itchy eyes/nose/throat, runny nose, and sneezing. This product contains a cough suppressant (such as chlophedianol) that affects a certain part of the brain, reducing the urge to cough. This product also contains a decongestant (such as pseudoephedrine, phenylephrine), which helps relieve stuffy nose symptoms. It also contains an antihistamine (such as brompheniramine, triprolidine, among others), which helps relieve watery eyes, itchy eyes/nose/throat, runny nose, and sneezing. This medication is not usually used for ongoing coughs from smoking, asthma, or other long-term breathing problems (such as emphysema), or for coughs with a lot of mucus, unless directed by your doctor. Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely. These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients (see also Drug Interactions section). Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms

How is this Aber Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67523010115. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
67523-101-15
11-Digit CMS (5-4-2)
67523-0101-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.